Chemokine/chemokine receptor interactions in extramedullary leukaemia of the skin in childhood AML: Differential roles for CCR2, CCR5, CXCR4 and CXCR7

Pediatric Blood and Cancer

Volumn 55, Issue 2, 2010, Pages 344-348

  Faaij, Claudia M J M ^a   Willemze, Annemieke J ^a   Révész, Tom ^b   Balzarolo, Melania ^a   Tensen, Cornelis P ^a   Hoogeboom, Manja ^a   Vermeer, Maarten H ^a   Van Wering, Elisabeth ^c   Zwaan, Christian M ^d   Kaspers, Gertjan J L ^e   Story, Colin ^b   Van Halteren, Astrid G S ^a   Vossen, Jaak M ^a   Egeler, R Maarten ^a   Van Tol, Maarten J D ^a   Annels, Nicola E ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b WOMEN S AND CHILDREN S HOSPITAL   (Australia)

^c DUTCH CHILDHOOD ONCOLOGY GROUP   (Netherlands)

^d SOPHIA CHILDREN S HOSPITAL   (Netherlands)

^e VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

AML; Chemokines; Paediatric haematology oncology

Indexed keywords

CHEMOKINE; CHEMOKINE RECEPTOR CCR1; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CX3CR1; CHEMOKINE RECEPTOR CXCR4; CHEMOKINE RECEPTOR CXCR7; CXCL11 CHEMOKINE; FRACTALKINE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ARTICLE; BLAST CELL; BLOOD CELL; BONE MARROW CELL; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GRANULOCYTIC SARCOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; SCHOOL CHILD; SKIN BIOPSY; SKIN CELL;

ADOLESCENT; CASE-CONTROL STUDIES; CHEMOKINES; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; LEUKEMIA, MYELOID, ACUTE; LEUKEMIC INFILTRATION; MALE; RECEPTORS, CCR2; RECEPTORS, CCR5; RECEPTORS, CHEMOKINE; RECEPTORS, CXCR; RECEPTORS, CXCR4; SKIN; SKIN NEOPLASMS;

EID: 77955100333     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.22500     Document Type: Article

References (23)

1. Tavor S, Petit I, Porozov S, et al. CXCR4 regulates migration and development of human acute myelogenous leukemia stem cells in transplanted NOD/SCID mice. Cancer Res 2004;64:2817-2824.
2. Kaspers GJ, Zwaan CM. Pediatric acute myeloid leukemia: Towards high-quality cure of all patients. Haematologica 2007;92:1519-1532.
3. Bisschop MM, Revesz T, Bierings M, et al. Extramedullary infiltrates at diagnosis have no prognostic significance in children with acute myeloid leukaemia. Leukemia 2001;15:46-49. (Pubitemid 32124067)
4. Kobayashi R, Tawa A, Hanada R, et al. Extramedullary infiltration at diagnosis and prognosis in children with acute myelogenous leukemia. Pediatr Blood Cancer 2007;48:393-398.
5. Mohle R, Schittenhelm M, Failenschmid C, et al. Functional response of leukaemic blasts to stromal cell-derived factor-1 correlates with preferential expression of the chemokine receptor CXCR4 in acute myelomonocytic and lymphoblastic leukaemia. Br J Haematol 2000;110:563-572.
6. Murphy PM. Chemokines and the molecular basis of cancer metastasis. N Engl J Med 2001;345:833-835.
7. Burger JA, Burkle A. The CXCR4 chemokine receptor in acute and chronic leukaemia: A marrow homing receptor and potential therapeutic target. Br J Haematol 2007;137:288-296.
8. Burger JA, Kipps TJ. CXCR4: A key receptor in the crosstalk between tumor cells and their microenvironment. Blood 2006;107:1761-1767.
9. Spoo AC, Lubbert M, Wierda WG, et al. CXCR4 is a prognostic marker in acute myelogenous leukemia. Blood 2007;109:786-791.
10. Crazzolara R, Kreczy A, Mann G, et al. High expression of the chemokine receptor CXCR4 predicts extramedullary organ infiltration in childhood acute lymphoblastic leukaemia. Br J Haematol 2001;115:545-553.
11. Voermans C, van Heese WP, de Jong I, et al. Migratory behavior of leukemic cells from acute myeloid leukemia patients. Leukemia 2002;16:650-657. (Pubitemid 34449747)
12. Balabanian K, Lagane B, Infantino S, et al. The chemokine SDF-1/CXCL12 binds to and signals through the orphan receptor RDC1 in T lymphocytes. J Biol Chem 2005;280:35760-35766.
13. Burns JM, Summers BC, Wang Y, et al. A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development. J Exp Med 2006;203:2201-2213.
14. Annels NE, Da Costa CE, Prins FA, et al. Aberrant chemokine receptor expression and chemokine production by Langerhans cells underlies the pathogenesis of Langerhans cell histiocytosis. J Exp Med 2003;197:1385-1390.
15. de Hooge AS, Berghuis D, Santos SJ, et al. Expression of cellular FLICE inhibitory protein, caspase-8, and protease inhibitor-9 in Ewing sarcoma and implications for susceptibility to cytotoxic pathways. Clin Cancer Res 2007;13:206-214.
16. Faaij CM, Lankester AC, Spierings E, et al. A possible role for CCL27/CTACK-CCR10 interaction in recruiting CD4 T cells to skin in human graft-versus-host disease. Br J Haematol 2006;133:538-549.
17. Allen SJ, Crown SE, Handel TM. Chemokine: Receptor structure, interactions, and antagonism. Annu Rev Immunol 2007;25:787-820.
18. Cignetti A, Vallario A, Roato I, et al. The characterization of chemokine production and chemokine receptor expression reveals possible functional cross-talks in AML blasts with monocytic differentiation. Exp Hematol 2003;31:495-503.
19. Bruserud O, Ryningen A, Olsnes AM, et al. Subclassification of patients with acute myelogenous leukemia based on chemokine responsiveness and constitutive chemokine release by their leukemic cells. Haematologica 2007;92:332-341. (Pubitemid 350143542)
20. Bruserud O. IL-4, IL-10 S and IL-13 in acute myelogenous leukemia. Cytokines Cell Mol Ther 1998;4:187-198.
21. Sozzani S, Ghezzi S, Iannolo G, et al. Interleukin 10 increases CCR5 expression and HIV infection in human monocytes. J Exp Med 1998;187:439-444.
22. Tavor S, Eisenbach M, Jacob-Hirsch J, et al. The CXCR4 antagonist AMD3100 impairs survival of human AML cells and induces their differentiation. Leukemia 2008;22:2151-2158.
23. Liesveld JL, Bechelli J, Rosell K, et al. Effects of AMD3100 on transmigration and survival of acute myelogenous leukemia cells. Leuk Res 2007;31:1553-1563.